Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
To assess the effect and toxicity of intrapleural administration of hypertonic cisplatin for
malignant pleural effusion in patients with non-small-cell lung cancer.